Little Green Pharma Ltd.(AU:LGP)
A$0.070.00 (0.00%)
AU:LGP
Little Green Pharma Ltd. financials statements
A$0.07
At close:0.00 (0.00%)
Want to see AU:LGP full AI Analyst Report?
Little Green Pharma Ltd. (LGP) Ratios
21 Followers
Little Green Pharma Ltd. Ratios
AU:LGP's free cash flow for Q4 2026 was AU$-606.00K. For the 2026 fiscal year, AU:LGP's free cash flow was decreased by AU$-415.00K and operating cash flow was AU$-191.00K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.48 | 2.60 | ― | 2.82 | 2.14 |
| Quick Ratio | 1.16 | 1.02 | ― | 2.01 | 1.65 |
| Cash Ratio | 0.20 | 0.27 | ― | 1.12 | 1.21 |
| Solvency Ratio | 0.22 | 0.63 | ― | -0.38 | -1.03 |
| Operating Cash Flow Ratio | 0.01 | -0.10 | ― | -0.63 | -1.04 |
| Short-Term Operating Cash Flow Coverage | 0.03 | -0.40 | ― | -1.06 | -1.43 |
| Net Current Asset Value | AU$ 13.76M | AU$ 11.61M | ― | AU$ 14.75M | AU$ 14.98M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.05 | ― | 0.12 | 0.17 |
| Debt-to-Equity Ratio | 0.06 | 0.05 | ― | 0.14 | 0.21 |
| Debt-to-Capital Ratio | 0.05 | 0.05 | ― | 0.13 | 0.17 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.01 | ― | 0.06 | 0.05 |
| Financial Leverage Ratio | 1.13 | 1.13 | ― | 1.20 | 1.27 |
| Debt Service Coverage Ratio | 1.09 | 2.77 | ― | -1.20 | -1.88 |
| Interest Coverage Ratio | -3.54 | -10.54 | ― | -8.21 | -39.15 |
| Debt to Market Cap | 0.12 | 0.08 | ― | 0.26 | 0.14 |
| Interest Debt Per Share | 0.02 | 0.02 | ― | 0.05 | 0.07 |
| Net Debt to EBITDA | 1.77 | -3.35 | ― | 0.11 | 0.16 |
| Profitability Margins | |||||
| Gross Profit Margin | 27.65% | 68.59% | ― | 61.21% | 32.13% |
| EBIT Margin | -4.62% | -11.97% | ― | -38.98% | 0.00% |
| EBITDA Margin | 4.36% | -1.86% | ― | -23.73% | -192.54% |
| Operating Profit Margin | -4.62% | -11.00% | ― | -38.98% | -202.07% |
| Pretax Profit Margin | -3.64% | -13.01% | ― | -43.73% | -193.92% |
| Net Profit Margin | -3.32% | 9.03% | ― | -47.04% | -171.43% |
| Continuous Operations Profit Margin | -3.32% | 9.03% | ― | 0.00% | -171.43% |
| Net Income Per EBT | 91.19% | -69.37% | ― | 107.58% | 88.40% |
| EBT Per EBIT | 78.82% | 118.35% | ― | 112.18% | 95.97% |
| Return on Assets (ROA) | -1.50% | 3.46% | ― | -9.33% | -25.09% |
| Return on Equity (ROE) | -1.70% | 3.91% | ― | -11.19% | -31.89% |
| Return on Capital Employed (ROCE) | -2.26% | -4.63% | ― | -8.71% | -35.73% |
| Return on Invested Capital (ROIC) | -2.03% | 3.13% | ― | -8.10% | -27.45% |
| Return on Tangible Assets | -1.56% | 3.62% | ― | -9.69% | -26.08% |
| Earnings Yield | -4.76% | 8.80% | ― | -20.47% | -21.04% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.97 | 9.29 | ― | 2.65 | 2.51 |
| Payables Turnover | 9.93 | 2.94 | ― | 2.26 | 2.98 |
| Inventory Turnover | 1.88 | 0.84 | ― | 0.85 | 1.16 |
| Fixed Asset Turnover | 0.75 | 0.61 | ― | 0.31 | 0.24 |
| Asset Turnover | 0.45 | 0.38 | ― | 0.20 | 0.15 |
| Working Capital Turnover Ratio | 2.70 | 2.64 | ― | 1.00 | 0.49 |
| Cash Conversion Cycle | 210.10 | 351.59 | ― | 404.78 | 336.57 |
| Days of Sales Outstanding | 52.33 | 39.30 | ― | 137.69 | 145.58 |
| Days of Inventory Outstanding | 194.51 | 436.45 | ― | 428.42 | 313.52 |
| Days of Payables Outstanding | 36.74 | 124.16 | ― | 161.34 | 122.53 |
| Operating Cycle | 246.84 | 475.75 | ― | 566.11 | 459.10 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | -0.00 | ― | -0.03 | -0.07 |
| Free Cash Flow Per Share | -0.00 | -0.00 | ― | -0.05 | -0.11 |
| Dividend Paid and CapEx Coverage Ratio | 0.05 | -0.22 | ― | -0.65 | -2.24 |
| Capital Expenditure Coverage Ratio | 0.05 | -3.87 | ― | -1.41 | -2.24 |
| Operating Cash Flow Coverage Ratio | 0.01 | -0.20 | ― | -0.58 | -1.08 |
| Operating Cash Flow to Sales Ratio | 0.00 | -0.02 | ― | -0.35 | -1.22 |
| Free Cash Flow Yield | -2.67% | -3.05% | ― | -26.39% | -21.70% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -21.09 | 11.36 | ― | -4.89 | -4.75 |
| Price-to-Sales (P/S) Ratio | 0.70 | 1.03 | ― | 2.30 | 8.15 |
| Price-to-Book (P/B) Ratio | 0.36 | 0.44 | ― | 0.55 | 1.52 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -37.45 | -32.74 | ― | -3.79 | -4.61 |
| Price-to-Operating Cash Flow Ratio | 758.71 | -41.20 | ― | -6.48 | -6.66 |
| Price-to-Earnings Growth (PEG) Ratio | 0.15 | -0.08 | ― | 0.08 | -0.02 |
| Enterprise Value Multiple | 17.77 | -58.59 | ― | -9.57 | -4.08 |
| Enterprise Value | 32.86M | 40.07M | ― | 44.44M | 110.21M |
| EV to EBITDA | 17.77 | -58.59 | ― | -9.57 | -4.08 |
| EV to Sales | 0.77 | 1.09 | ― | 2.27 | 7.85 |
| EV to Free Cash Flow | -41.60 | -34.73 | ― | -3.74 | -4.44 |
| EV to Operating Cash Flow | 842.64 | -43.70 | ― | -6.40 | -6.42 |
| Tangible Book Value Per Share | 0.26 | 0.27 | ― | 0.31 | 0.30 |
| Shareholders’ Equity Per Share | 0.27 | 0.28 | ― | 0.33 | 0.32 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.09 | 1.69 | ― | -0.51 | 0.12 |
| Revenue Per Share | 0.14 | 0.12 | ― | 0.08 | 0.06 |
| Net Income Per Share | -0.00 | 0.01 | ― | -0.04 | -0.10 |
| Tax Burden | 0.91 | -0.69 | ― | 1.08 | 0.88 |
| Interest Burden | 0.79 | 1.09 | ― | 1.12 | 0.00 |
| Research & Development to Revenue | 0.00 | 0.01 | ― | 0.34 | 0.51 |
| SG&A to Revenue | 0.51 | 0.61 | ― | 0.24 | 1.22 |
| Stock-Based Compensation to Revenue | 0.00 | 0.07 | ― | 0.12 | 0.17 |
| Income Quality | -0.03 | -0.28 | ― | 0.81 | 0.71 |
Currency in AUD

